Clinical Trials

Showing 1 - 20 of 509 trials
Title Investigatorsort icon Disease(s)
A Phase II Study of Sorafenib plus Doxorubicin in Patients with Liver Cancer that Continued Growing with Sorafenib Therapy
[Protocol 12-259]
Abou-Alfa, Ghassan
  • Hepatobiliary
    • Liver Cancer
A Phase III Study of Cabozantinib versus Placebo in Patients with Liver Cancer Who Received Previous Therapy with Sorafenib
[Protocol 13-151]
Abou-Alfa, Ghassan
  • Hepatobiliary
    • Liver Cancer
A Phase III Study of Sorafenib plus Doxorubicin versus Sorafenib Alone in Patients with Advanced Hepatocellular Cancer
[Protocol 11-039]
Abou-Alfa, Ghassan
  • Hepatobiliary
    • Liver Cancer
A Phase II Study of Everolimus, Leuprolide/Letrozole, and Everolimus/Leuprolide/Letrozole in Patients with Inoperable Fibrolamellar Hepatocellular Carcinoma
Newly Diagnosed & Relapsed/Refractory
[Protocol 11-211]
Abou-Alfa, Ghassan
  • Hepatobiliary
    • Liver Cancer
A Phase IB Study of Dalantercept plus Sorafenib in Patients with Advanced Liver Cancer
[Protocol 14-092]
Abou-Alfa, Ghassan
  • Hepatobiliary
    • Liver Cancer
A Phase II/III Study of Paclitaxel/Carboplatin with and without Metformin for Treating Stage III or IV or Recurrent Endometrial Cancer
[Protocol 14-081]
Aghajanian, Carol
  • Uterine (Endometrial) Cancer
Cognition in Older Breast Cancer Survivors: Influence of Treatment, Genetics, and Smoking History
[Protocol 14-071]
Ahles, Tim
  • Breast Cancer
  • Survivorship
Risk for Cognitive Decline in Older Women with Breast Cancer
[Protocol 10-079]
Ahles, Tim
  • Breast Cancer
Care for the Cancer Caregiver: A Meaning-Based Workshop to Help Manage Caregiver Burden
Newly Diagnosed & Relapsed/Refractory
[Protocol 14-208]
Applebaum, Allison
  • Psychiatry & Behavioral Sciences
  • Quality of Life
A Phase II Study of Ipilimumab Plus Isolated Limb Infusion with Melphalan and Dactinomycin to Treat Advanced Unresectable Melanoma of the Extremity
[Protocol 10-101]
Ariyan, Charlotte
  • Melanoma
A Study Comparing Standard Fluid Management with a Device for Goal-Directed Fluid Management in Patients Undergoing Bladder Removal Surgery
Newly Diagnosed & Relapsed/Refractory
[Protocol 14-069]
Arslan Carlon, Vittoria
  • Bladder Cancer
A Phase I Study of AM0010 in Patients with Advanced Solid Tumors
[Protocol 13-224]
Autio, Karen
  • Colorectal Cancer
  • Hepatobiliary
    • Pancreatic Cancer
  • Kidney Cancer
  • Lung Cancer
  • Melanoma
  • Ovarian Cancer
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
  • Upper Gastrointestinal
    • Pancreatic Cancer
A Phase II Study of Degarelix plus Ipilimumab with Radical Prostatectomy in Men Newly Diagnosed with Metastatic Prostate Cancer
[Protocol 13-134]
Autio, Karen
  • Prostate Cancer
A Phase II Study of Neoadjuvant Dose-Dense Gemcitabine and Cisplatin in Patients with Muscle-Invasive Bladder Cancer
[Protocol 12-071]
Bajorin, Dean
  • Bladder Cancer
A Genotype-Phenotype Urothelial Cancer Study
[Protocol 09-025]
Bajorin, Dean
  • Bladder Cancer
  • Hereditary Cancer & Genetics
A Phase I Study of BGJ398 in Patients with Advanced Urothelial Cancers
[Protocol 14-218]
Bajorin, Dean
  • Bladder Cancer
  • Kidney Cancer
A Phase II Study of Gemcitabine, Carboplatin, and Panitumumab Given Before Surgery in Patients with Muscle-Invasive Bladder Cancer
[Protocol 10-103]
Bajorin, Dean
  • Bladder Cancer
A Phase II Study of BKM120 in Metastatic Transitional Cell Carcinoma of the Urothelium
[Protocol 11-060]
Bajorin, Dean
  • Bladder Cancer
A Phase III Study of Surgery Followed by Radiation Therapy or Observation in Patients with Neurotropic Melanoma of the Head and Neck
[Protocol 13-248]
Barker, Christopher
  • Melanoma
A Phase II Study of Vismodegib plus Radiation Therapy for Locally Advanced Basal Cell Cancers of the Head and Neck
[Protocol 14-022]
Barker, Christopher
  • Basal Cell Carcinoma
  • Head & Neck Cancer